Viewing Study NCT00226668


Ignite Creation Date: 2025-12-24 @ 5:40 PM
Ignite Modification Date: 2026-01-05 @ 5:09 PM
Study NCT ID: NCT00226668
Status: WITHDRAWN
Last Update Posted: 2008-01-03
First Post: 2005-09-23
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: XERECEPT® (hCRF) for Primary Glioma Patients Requiring Dexamethasone to Treat Peritumoral Brain Edema
Sponsor: Celtic Pharma Development Services
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module